3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 3
1
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Stomach Neoplasms
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Parathyroid Diseases
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroma
1
Neoplasms
1
Lymphatic Metastasis
1
Hypoparathyroidism
1
Graves Disease
1
Goiter
1
Giant Cell Tumor of Tendon Sheath
1
Giant Cell Tumor of Bone
1
Erectile Dysfunction
1
Endometrial Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Anastomotic Leak
1
Adenoma
1
Interventions
niraparib
4
olaparib
2
apatinib
2
Sevoflurane
2
Saline Solution
2
Propofol
2
Carboplatin
2
Bevacizumab
2
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
pazopanib
1
palbociclib
1
liposomal doxorubicin
1
lenvatinib
1
gadofosveset trisodium
1
fosaprepitant
1
ferrous fumarate
1
Tranexamic Acid
1
Trabectedin
1
Sunitinib
1
Sodium Chloride
1
Pharmacokinetics
1
Patient-Specific Modeling
1
Pafolacianine
1
Paclitaxel
1
LY 353381
1
Injections
1
Indocyanine Green
1
Folic Acid
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Ovarian Neoplasms
×
Indocyanine Green
×
Clear all
NCT06871787
2025-03-14
INOCA
Istanbul University
Phase 4
Not yet recruiting
50 enrolled